Mayne Pharma Rebukes Cosette’s Latest Termination Threat Over FDA Disclosure

• Cosette alleges Mayne Pharma breached scheme implementation deed over FDA Untitled Letter disclosures
• Mayne Pharma denies any new disclosure obligations and rejects termination notice as invalid
• Dispute centers on interpretation of continuous disclosure and misleading conduct clauses
• Mayne Pharma intends to enforce rights through ongoing court proceedings